Contango Silver & Gold (CTGO) is a small-cap junior gold producer with three assets: a 30% interest in the Manh Choh JV (Kinross-operated Alaska mine), 100% of Lucky Shot (Alaska, 2028 production target), and Kitsault Valley (British Columbia, acquired via March 2026 Dolly Varden merger). Q1 2026 10-Q filed May 14.

What the filing says

Hedge book down 30%. Derivative liability $103.7M → $72.2M. CTGO used $50.9M of February offering proceeds to cash-settle 15,446 oz at $2,025 strike (gold spot ≈$4,800-5,000). Remaining: 7,000 oz in 2026, 15,000 oz in 2027 at $1,933. Per the Credit Agreement amendment, the 2027 tranche extends to June 30, 2027 — directly contradicting management's repeated "hedge and debt free by end 2026" claim. The fourth documented overstatement in CTGO investor communications.

Lucky Shot freehold acquisition (Note 20, subsequent events). May 4, 2026 PSA with Alaska Hardrock Inc.: $16.1M total ($6.1M cash + $10M secured promissory note, 5%, 4-year) for 100% freehold ownership AND extinguishment of AHI's 2% NSR royalty. At Lucky Shot's target 45K GEO/yr and gold $3,200/oz, the NSR was worth $2.88M/yr. NPV at 20x ≈ $48-58M; cost $16.1M; net unlock $32-42M. No standalone 8-K Item 1.01 filed within the 4-business-day SEC window; disclosure was via 10-Q subsequent events only.

Manh Choh Q1 was light. CTGO 30% share: 6,187 oz, $9M JV distribution (vs $24M Q1 2025, $33M Q3 2025). Company maintains FY2026 40-45K GEO guidance — requires ≈2x Q1 rate for Q2-Q4.

What the market thinks

The post-print drop prices Q1 weakness as transitional. Pre-print, the stock implied ~+25-30% over 18mo against the prior worldview scenario (EV $31, +38.1%); post-print implies roughly +10-20%. Probability-weighted estimate over 18mo: +8.5% to $24.35. Price is close to fair, with mild bearish skew vs market consensus.

The synthesis the market hasn't done: Kinross's Q1 2026 6-K (April 29) discloses the full Manh Choh quarterly trajectory. Q3 2025 = 7.05 g/t. Q4 2025 = 4.08 g/t. Q1 2026 = 4.51 g/t. The grade collapse happened in Q4 2025, not Q1 2026. CTGO's $15M Q4 2025 distribution (vs $33M Q3) was the first signal — attributed at the time to working capital. Kinross stripped "on plan" Manh Choh language from its Q1 2026 commentary; analysts asked no questions.

Why the gap exists

Two pieces of public information that together break the "Q1 noise" narrative. The connection requires reading CTGO MD&A and KGC's footnote g — neither is interesting in isolation. Kinross's Manh Choh exposure is ≈12% of attributable production, so it has no incentive to make asset-specific reassurances. CTGO bears the weight of explaining a trajectory it doesn't fully control. Sell-side coverage is thin.

The Lucky Shot royalty deal is buried in Note 20; the May 5 press release exists, but the market is reacting to production weakness, not the offsetting NPV unlock.

Regression: CTGO sits at 35-42% idiosyncratic variance (below the 75% Paleologo target), β_GDXJ ≈ 1.0-1.3, β_SPY ≈ 1.4 post-merger. The stock is more junior-gold-sector exposure than idio bet right now. α_orth/σ_idio = 0.10-0.31 — below the 0.5-1.0 plausibility band. Real edge is small (≈1-4% net) and concentrated in three places: the Manh Choh forecast disconnect (90-day window), the Lucky Shot royalty unlock (disclosure asymmetry), and the hedge timing misrepresentation.

Risks (ranked)

  1. Manh Choh South Pit ramp fails. Two-quarter grade pattern continues. FY2026 guidance cut. FY2027 distribution thesis ($165-175M company guidance vs our $130M estimate) impaired further. Aug 12 is the binary.
  2. Sector β. β_GDXJ ≈ 1.0-1.3 — CTGO follows junior gold sector regardless of idio outcome.
  3. Management credibility erosion. Four overstatements (SIL inclusion, SILJ AUM 2.2x, Alyeska ownership framing, "hedge-free by end 2026"). Compounds.
  4. Lucky Shot timeline slippage. No formal S-K 1300 release despite drill data in hand. FS H1 2027, production target 2028. Each slip compounds NPV decay.

Catalysts

  • Aug 12, 2026 — Q2 2026 earnings. South Pit production binary.
  • Jul 1, 2026 — Lucky Shot freehold closing (88%).
  • Jul 31, 2026 — Kitsault Valley MRE update (70%).
  • Aug 31, 2026 — formal S-K 1300 Lucky Shot drill release (60%).
  • Dec 31, 2026 — 2026 hedge tranche cleared (55%, downgraded from 80%).
  • H1 2027 — Lucky Shot feasibility study.
  • 2028 — Lucky Shot production start.

What would change our mind

  • Q2 Manh Choh grade > 5.5 g/t → two-quarter pattern was transitional; thesis recovers.
  • KGC publishes Manh Choh-specific FY26 production guidance → operator-side commitment.
  • Formal S-K 1300 Lucky Shot release with M&I resource > 400K GEO.
  • Insider Form 4 P-codes in the 90 days before Aug 12.
  • Stock to $19-20 → P/NAV ≈ 1.2-1.3x mid; entry edge becomes real.
  • Stock to $15 or below → 0.9x P/NAV mid; valuation support improves materially if Lucky Shot/Kitsault optionality remains intact.

Evidence

EvidenceSourceCredibilityLR
Lucky Shot freehold PSA: $16.1M total ($6.1M cash + $10M 5%/4-yr note) for 100% ownership + 2% NSR extinguishment10-Q 2026-05-14, Note 20 Subsequent Events0.952.0
NSR elimination NPV: $32-42M net unlocked vs $16.1M cost (45K GEO/yr × $3,200/oz × 20x)10-Q Note 20 + analysis0.901.8
Hedge liability $103.7M → $72.2M; $50.9M cash settled 15,446 oz at $2,025 strike10-Q Note 14 Derivatives0.951.6
Junior gold operator pre-FS royalty buyback pattern (Roxgold, Galleon, Erdene, Arizona Sonoran)Cross-ticker analysis0.851.3
GAAP/cash disconnect: $50.9M realized loss is one-time hedge settlement10-Q Note 14 + cash flow0.951.3
Dolly Varden as asset acquisition: $287.6M mineral properties, no goodwill, $56.1M DTL10-Q Note 4 Acquisition0.951.2
2027 hedge tranche (15K oz at $1,933) extends to June 2027 per Credit Agreement; contradicts "hedge-free end 2026" claim10-Q Notes 13-140.950.85
Q1 production CTGO share 6,187 oz; $9M distribution vs $24M Q1 2025; North Pit grade transition explanation10-Q MD&A + Note 50.950.85
Manh Choh two-quarter grade pattern: Q3 7.05 g/t → Q4 4.08 g/t → Q1 4.51 g/tKGC Q1 2026 6-K footnote g + CTGO 10-Q reconciliation0.950.7
Management credibility: 4 documented investor-comm overstatements compoundingCross-source verification0.900.8